Cargando…

Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer

SIMPLE SUMMARY: Recurrences after primary resection of pancreatic cancer are generally treated with chemotherapy or best supportive care. Despite some reports of encouraging results after the re-resection of recurrences, the real role of surgery in this setting remains unclear. The aim of our system...

Descripción completa

Detalles Bibliográficos
Autores principales: Serafini, Simone, Sperti, Cosimo, Friziero, Alberto, Brazzale, Alessandra Rosalba, Buratin, Alessia, Ponzoni, Alberto, Moletta, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998253/
https://www.ncbi.nlm.nih.gov/pubmed/33805716
http://dx.doi.org/10.3390/cancers13061277
_version_ 1783670509523697664
author Serafini, Simone
Sperti, Cosimo
Friziero, Alberto
Brazzale, Alessandra Rosalba
Buratin, Alessia
Ponzoni, Alberto
Moletta, Lucia
author_facet Serafini, Simone
Sperti, Cosimo
Friziero, Alberto
Brazzale, Alessandra Rosalba
Buratin, Alessia
Ponzoni, Alberto
Moletta, Lucia
author_sort Serafini, Simone
collection PubMed
description SIMPLE SUMMARY: Recurrences after primary resection of pancreatic cancer are generally treated with chemotherapy or best supportive care. Despite some reports of encouraging results after the re-resection of recurrences, the real role of surgery in this setting remains unclear. The aim of our systematic review and meta-analysis was to define the benefit of surgery in the case of isolated local recurrence. The data collected on 431 patients suggest an overall survival benefit of 29 months for patients re-operated compared to patients given medical therapies. In selected patients with recurrent pancreatic cancer, resection is safe and feasible, and may offer a survival advantage. ABSTRACT: Purpose: To perform a systematic review and meta-analysis on the outcome of surgical treatment for isolated local recurrence of pancreatic cancer. Methods: A systematic review and meta-analysis based on Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines was conducted in PubMed, Scopus, and Web of Science. Results: Six studies concerning 431 patients with recurrent pancreatic cancer met the inclusion criteria and were included in the analysis: 176 underwent redo surgery, and 255 received non-surgical treatments. Overall survival and post-recurrence survival were significantly longer in the re-resected group (ratio of means (ROM) 1.99; 95% confidence interval (CI), 1.54–2.56, I(2) = 75.89%, p = 0.006, and ROM = 2.05; 95% CI, 1.48–2.83, I(2) = 76.39%, p = 0.002, respectively) with a median overall survival benefit of 28.7 months (mean difference (MD) 28.7; 95% CI, 10.3–47.0, I(2) = 89.27%, p < 0.001) and median survival benefit of 15.2 months after re-resection (MD 15.2; 95% CI, 8.6–21.8, I(2) = 58.22%, p = 0.048). Conclusion: Resection of isolated pancreatic cancer recurrences is safe and feasible and may offer a survival benefit. Selection of patients and assessment of time and site of recurrence are mandatory.
format Online
Article
Text
id pubmed-7998253
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79982532021-03-28 Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer Serafini, Simone Sperti, Cosimo Friziero, Alberto Brazzale, Alessandra Rosalba Buratin, Alessia Ponzoni, Alberto Moletta, Lucia Cancers (Basel) Systematic Review SIMPLE SUMMARY: Recurrences after primary resection of pancreatic cancer are generally treated with chemotherapy or best supportive care. Despite some reports of encouraging results after the re-resection of recurrences, the real role of surgery in this setting remains unclear. The aim of our systematic review and meta-analysis was to define the benefit of surgery in the case of isolated local recurrence. The data collected on 431 patients suggest an overall survival benefit of 29 months for patients re-operated compared to patients given medical therapies. In selected patients with recurrent pancreatic cancer, resection is safe and feasible, and may offer a survival advantage. ABSTRACT: Purpose: To perform a systematic review and meta-analysis on the outcome of surgical treatment for isolated local recurrence of pancreatic cancer. Methods: A systematic review and meta-analysis based on Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines was conducted in PubMed, Scopus, and Web of Science. Results: Six studies concerning 431 patients with recurrent pancreatic cancer met the inclusion criteria and were included in the analysis: 176 underwent redo surgery, and 255 received non-surgical treatments. Overall survival and post-recurrence survival were significantly longer in the re-resected group (ratio of means (ROM) 1.99; 95% confidence interval (CI), 1.54–2.56, I(2) = 75.89%, p = 0.006, and ROM = 2.05; 95% CI, 1.48–2.83, I(2) = 76.39%, p = 0.002, respectively) with a median overall survival benefit of 28.7 months (mean difference (MD) 28.7; 95% CI, 10.3–47.0, I(2) = 89.27%, p < 0.001) and median survival benefit of 15.2 months after re-resection (MD 15.2; 95% CI, 8.6–21.8, I(2) = 58.22%, p = 0.048). Conclusion: Resection of isolated pancreatic cancer recurrences is safe and feasible and may offer a survival benefit. Selection of patients and assessment of time and site of recurrence are mandatory. MDPI 2021-03-13 /pmc/articles/PMC7998253/ /pubmed/33805716 http://dx.doi.org/10.3390/cancers13061277 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Serafini, Simone
Sperti, Cosimo
Friziero, Alberto
Brazzale, Alessandra Rosalba
Buratin, Alessia
Ponzoni, Alberto
Moletta, Lucia
Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer
title Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer
title_full Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer
title_fullStr Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer
title_full_unstemmed Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer
title_short Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer
title_sort systematic review and meta-analysis of surgical treatment for isolated local recurrence of pancreatic cancer
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998253/
https://www.ncbi.nlm.nih.gov/pubmed/33805716
http://dx.doi.org/10.3390/cancers13061277
work_keys_str_mv AT serafinisimone systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer
AT sperticosimo systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer
AT frizieroalberto systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer
AT brazzalealessandrarosalba systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer
AT buratinalessia systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer
AT ponzonialberto systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer
AT molettalucia systematicreviewandmetaanalysisofsurgicaltreatmentforisolatedlocalrecurrenceofpancreaticcancer